MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-DL-03-0007417
Quad Lifesciences Private Limited - pharma in Derabassi, Punjab, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹123.66 Cr
▲ 26% YoY
Net profit · FY 2025
₹7.04 Cr
Net margin 5.7%
EBITDA · FY 2025
₹14.94 Cr
EBITDA margin 12.1%
Authorised capital
₹12.5 Cr
Registered with MCA
Paid-up capital
₹12.43 Cr
Issued & subscribed
Open charges
₹42.29 Cr
Satisfied ₹11.83 Cr
Company age
14 yrs
Est. 2012
Employees · EPFO
134
Provident fund records
About Quad Lifesciences Private Limited
Data last updated:
Quad Lifesciences Private Limited is a private limited company based in Derabassi, Punjab, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 26 March 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB2012PTC038263. Its GSTIN is 06AAACQ2750L1ZE (Haryana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹12.5 Cr and a paid-up capital of ₹12.43 Cr. It is led by directors Meera Pruthi and Om Parkash Sharma.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #6Km Near Ind – Swift Factory Village Bhagwanpur Dearbassi – Barwala Road Tehsil Derabassi, Punjab, India – 140507.
As per the financials filed for FY 2025, the company reported a revenue of ₹123.66 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹7.04 Cr (net margin 5.7%) and EBITDA of ₹14.94 Cr (EBITDA margin 12.1%). Revenue has grown at a compounded annual rate (CAGR) of 13% over five years.
The company has about 134 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Quadlife Sciences. As per MCA filings, the company has open charges of ₹42.29 Cr and satisfied charges of ₹11.83 Cr on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 3 cases are pending. The company has 6 deals on record (3 funding rounds, 3 secondary share transfers), with disclosed funding of ₹12.15 Cr; the latest was in January 2020. Its 8 peer companies in the Pharma industry (API Manufacturers, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 3 smaller; the largest is Coral Drugs Private Limited with revenue of ₹126.9 Cr.
Quad Lifesciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0007417). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website quadlifesciences.com.
Company details
CIN U24232PB2012PTC038263
Registration Number 038263
Incorporation Date 26 March 2012
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-03-0007417
CIN history
Quad Lifesciences has one previous CIN (Corporate Identification Number): U24232CH2012PTC033660. The current CIN is U24232PB2012PTC038263, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232PB2012PTC038263 | Current |
| U24232CH2012PTC033660 | Previous |
Recognitions & Rankings of Quad Lifesciences
Contact details
Quad Lifesciences Private Limited's registered office is in Derabassi, Punjab. Its website is quadlifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address#6Km Near Ind – Swift Factory Village Bhagwanpur Dearbassi – Barwala Road Tehsil Derabassi, Punjab, India – 140507
- IndustryPharma, API Manufacturers
To see the full contact details of Quad Lifesciences Private Limited, buy the company report.
Comprehensive company report
Quad Lifesciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Quad Lifesciences operates one associated brand: Quadlife Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and supplies phytochemical and standardized herbal extracts. | quadlifesciences.com |
Business activity
The main business activity of Quad Lifesciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Quad Lifesciences Private Limited, buy the company report.
Financials of Quad Lifesciences Private Limited
FY 2025 filings availableQuad Lifesciences Private Limited reported revenue of ₹123.66 Cr (up 26% YoY) for FY 2025.
Revenue · FY 2025
₹123.66 Cr ▲ 26%
Net profit · FY 2025
₹7.04 Cr margin 5.7%
EBITDA · FY 2025
₹14.94 Cr margin 12.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 26%
5 years · compounded
▲ 13%
EBITDA CAGR growth
3 years · compounded
▼ 9%
5 years · compounded
▲ 12%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 26% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.94 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.04 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.1% | ||||
| Net Profit Margin | 5.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Quad Lifesciences Private Limited, buy the company report.
Board of directors and KMP of Quad Lifesciences Private Limited
Quad Lifesciences Private Limited currently reports 2 directors and 1 key managerial person. 9 former directors have served the organization.
Current Directors and KMP
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samir Pruthi | Ceo | 01 Apr 2021 | 5 Years 7 Months | Current |
| Meera Pruthi Also directs: Aaloha Lifesciences Private Limited, Vinman Health Private Limited, Vivaar Exim Private Limited and 1 more | Director | 01 Oct 2012 | 14 Years 1 Months | Current |
| Om Parkash Sharma | Director | 05 Feb 2014 | 12 Years 9 Months | Current |
Peer comparison
Quad Lifesciences Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Coral Drugs Private Limited | ₹126.9 Cr (FY 2025) | 11.0% | New Delhi, Delhi, India | |||
| Sohan Healthcare Private Limited | ₹126.69 Cr (FY 2025) | 6.0% | Yavatmal, Maharashtra, India | |||
| Corey Organics Private Limited | ₹126.33 Cr (FY 2025) | -6.0% | Hyderabad, Telangana, India | |||
| Smruthi Organics Ltd | ₹126.1 Cr (FY 2025) | -1.0% | Solapur, Maharashtra, India | |||
| Alcon Biosciences Private Limited | ₹125.22 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Quad Lifesciences Private Limitedthis company | ₹123.66 Cr (FY 2025) | ₹7.04 Cr | 5.7% | 26.0% | 134 | Derabassi, Punjab, India |
| Roopa Industries Limited | ₹122.98 Cr (FY 2025) | 72.0% | Kurnool, A.P, Andhra Pradesh, India | |||
| Richter Themis Medicare (India) Private Limited | ₹122.69 Cr (FY 2025) | -13.0% | Valsad, Gujarat, India | |||
| Nuray Chemicals Private Limited | ₹122.27 Cr (FY 2025) | 16.0% | Thiruvallur, Tamil Nadu, India |
To see the full peer comparison of Quad Lifesciences Private Limited, buy the company report.
Auditor
Quad Lifesciences Private Limited is audited by SKD & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SKD & Associates | FY 2023 | 023842N |
Shareholding
The shareholding of Quad Lifesciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Quad Lifesciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹42.29 Cr
Satisfied charges
₹11.83 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Nov 2021 | 100499102 | Others | ₹1.29 Cr | Open | |
| 20 Nov 2017 | 100148450 | Yes Bank Limited | ₹11 Cr | Open | |
| 18 Sep 2013 | 10453059 | Canara Bank | ₹30 Cr | Open | |
| 17 Aug 2018 | 100198885 | Others | ₹2 Cr | Satisfied | |
| 16 Dec 2015 | 10612041 | Canara Bank | ₹50 Lakh | Satisfied |
To see the full charge records of Quad Lifesciences Private Limited, buy the company report.
Total charge records: 10 View all charges
Deals & funding
Quad Lifesciences Private Limited has 6 deals on record (3 funding rounds, 3 secondary share transfers), with disclosed funding of ₹12.15 Cr; the latest was in January 2020.
Total deals
6
Funding rounds
3
Secondary share transfers
3
Disclosed funding
₹12.15 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2020 | Secondary share transfer | Undisclosed | Buyer: Girisha Lifesciences Private Limited Seller: Barfani Baba Pharma Private Limited |
| Mar 2015 | Funding round | ₹1.3 Cr | Investors: Vinman Health Private Limited , Aaloha Lifesciences Private Limited , 2 individuals |
| Sep 2013 | Funding round | ₹8.3 Cr | Investors: Vinman Health Private Limited , Barfani Baba Pharma Private Limited , Aaloha Lifesciences Private Limited |
| Sep 2013 | Secondary share transfer | Undisclosed | Buyer: Barfani Baba Pharma Private Limited , Aaloha Lifesciences Private Limited , Vivaar Exim Private Limited Seller: Amos Biosciences Private Limited , 3 individuals |
| May 2012 | Funding round | ₹2.55 Cr | Investors: Amos Biosciences Private Limited |
To see the full deal history of Quad Lifesciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Quad Lifesciences Private Limited has 4 court cases on record: 3 filed by Quad Lifesciences, 1 filed against it. 3 cases are pending and 1 is disposed.
Total cases
4
Filed by the company
3
Filed against the company
1
Pending
3
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 1 | 3 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Court case (CS (COMM.)) | Filed by the company against an individual | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against Pharminox Laboratories Through Its Partners | Pending |
| District court, Kurukshetra, Haryana | Commercial suit | Filed against the company by an individual | Disposed |
To see the full case history of Quad Lifesciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Quad Lifesciences Private Limited was last rated by Crisil on 24 Dec 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 24 Dec 2021 |
To see the full credit ratings and regulatory alerts of Quad Lifesciences Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Quad Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Quad Lifesciences Private Limited has a workforce of 134 employees on its EPFO records as of Apr 2026, across 2 active EPFO establishments.
Employee count
134
Active EPFO establishments
2
Employee growth
-8.2%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 134 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Quad Lifesciences Private Limited, buy the company report.
GST
Quad Lifesciences has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAACQ2750L1ZE | Haryana | Active | 15 Sep 2020 |
To see the full GST registrations and return filing status of Quad Lifesciences Private Limited, buy the company report.
Recent activity
Quad Lifesciences Private Limited has 10 board changes on record since 2012: 3 appointments and 7 cessations. The latest: Samir Pruthi was appointed as CEO on 01 Apr 2021.
AGM
Quad Lifesciences Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge with Canara Bank of Rs. 30.00 Cr registered on 18 Sep 2013 with Charge ID 10453059 was modified on 10 Jun 2025.
Filing
Quad Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge with Others amounted to Rs. 1.29 Cr with Charge ID 100499102 was registered on 01 Nov 2021.
Appointed
Samir Pruthi was appointed as CEO.
Charges
A charge registered on 17 Aug 2018 via Charge ID 100198885 with Others was fully satisfied on 03 Oct 2020.
Charges
A charge registered on 17 Oct 2014 via Charge ID 10530312 with Canara Bank was fully satisfied on 19 Jun 2020.
Charges
A charge registered on 20 Aug 2014 via Charge ID 10518942 with Canara Bank was fully satisfied on 15 Jun 2020.
Charges
A charge registered on 20 May 2014 via Charge ID 10496156 with Canara Bank was fully satisfied on 15 Jun 2020.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100198885 was registered on 17 Aug 2018.
Charges
A charge registered on 16 Feb 2015 via Charge ID 10552594 with Canara Bank was fully satisfied on 14 Feb 2018.
Charges
A charge registered on 16 Dec 2015 via Charge ID 10612041 with Canara Bank was fully satisfied on 06 Feb 2018.
20 earlier events are in the company report.
Frequently asked questions
Quad Lifesciences is an active private limited company based in Derabassi, Punjab, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 26 March 2012 (14+ years old) and is registered under CIN U24232PB2012PTC038263.
Quad Lifesciences has 3 current directors and KMP:
- Meera Pruthi - Director
- Om Parkash Sharma - Director
- Samir Pruthi - Ceo
The latest financial statements of Quad Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Quad Lifesciences is 06AAACQ2750L1ZE, registered in Haryana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Quad Lifesciences is U24232PB2012PTC038263. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Quad Lifesciences has 4 court cases on record: 3 filed by the company and 1 filed against it. 3 are pending.
Quad Lifesciences was incorporated on 26 March 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chandigarh.
Quad Lifesciences has 6 deals on record (3 funding rounds, 3 secondary share transfers), with disclosed funding of ₹12.15 Cr; the latest was in January 2020.
The peers of Quad Lifesciences by revenue are Coral Drugs Private Limited, Sohan Healthcare Private Limited, Corey Organics Private Limited, Smruthi Organics Ltd, Alcon Biosciences Private Limited and 3 more, all in the Pharma industry (API Manufacturers, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Samir Pruthi was appointed as CEO on 01 Apr 2021. Om Parkash Sharma ceased to be Additional Director on 30 Sep 2014. Rakesh Kumar Girdhar ceased to be Director on 06 Feb 2014. Quad Lifesciences has 10 board changes on record in total.
Yes, Quad Lifesciences is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-03-0007417).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages